Pfizer Inc.
NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME

Abstract:

Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of ##STR00001## as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.